WOW0821240209BLCLJLLLML

My Cart
Checkout Secure

CBD IN THE NEWS


https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm611046.htm

https://www.forbes.com/sites/tomangell/2018/06/28/u-s-senate-votes-to-legalize-hemp-after-decades-long-ban-under-marijuana-prohibition/?fbclid=IwAR3Atf9H6VB4E6GXjpVlDmYtkaUpc6pXEOAMfAWBGZmfjhYi1nKIX0QGWC8#1abba7a6418a

In 2018 The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome.

In 2018 The U.S. Food and Drug Administration has also granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of Skin Cancer.

 https://www.forbes.com/sites/bethkaiserman/2018/12/05/cbd-companies-prepare-for-hemp-legalization-in-farm-bill/#710af8c45627

 
Added to cart!